Some scholars (62) found that aberrant activation of WNT/β-catenin was associated with TP53 mutations after treatment with 5-fluorouracil through CRC PDOs, explaining the possibility that most colorectal cancers are resistant to treatment with 5-fluorouracil alone. This evidence concerns the gene TP53 and colorectal carcinoma.